Turning Tumors Into Their Own Immunotherapies - Lewis Bender - CEO, Intensity Therapeutics, Inc., joins me on Progress, Potential, And Possibilities #Intratumoral #Immunotherapy #NeoantigenRelease #AdaptiveImmuneResponse
www.youtube.com/watch?v=75vl...